CRSP icon

CRISPR Therapeutics
CRSP

Overview Fund Trends Analyst Outlook Journalist POV

26 hedge funds and large institutions have $198M invested in CRISPR Therapeutics in 2016 Q4 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
26
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$65.3M
2
+$52M
3
+$16.7M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$15M
5
Franklin Resources
Franklin Resources
California
+$14.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$65.3M
2
$52M
3
$16.7M
4
$15M
5
$14.4M
6
$11.9M
7
$7.54M
8
$4.52M
9
$4.29M
10
$3.02M
11
$1.22M
12
$527K
13
$436K
14
$371K
15
$241K
16
$146K
17
$82K
18
$77K
19
$20K
20
$13K
21
$12K
22
$10K
23
$7K
24
$6K
25
$2K
1
2